Announcements

Archive by year: 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |

Date	Title	Format
21/12/2004	Director's Interests
14/12/2004	ReGen Therapeutics Plc Placing raises £1.25m
13/12/2004	Research Update
10/12/2004	ReGen Therapeutics Plc establishes Level-1 American Depositary Receipt Programme (+ FAQ's as PDF)
10/12/2004	Annual City Presentation
17/11/2004	Holding(s) in Company
25/10/2004	Completion of Acquisition of Guildford Clinical Pharmacology Unit Limited
19/10/2004	Regen Therapeutics Plc to acquire Guildford Clinical Pharmacology Unit Limited
07/10/2004	Substantial Shareholding
15/09/2004	Interim Results for the Six Months to 30 June 2004
06/09/2004	Reduction of Memory Impairment
22/07/2004	Pre-treatment of Cells with Colostrinin™ Prevents Aggregation and Toxicity of Beta Amyloid
16/06/2004	In-vivo Study in Chicks shows ReGen's Colostrinin™ enhances memory
20/05/2004	US Laboratory Studies show the potential of ReGen's ColostrininTM to impact pathologies involved in Alzheimer's disease
20/04/2004	AGM Statement
20/04/2004	Results of Annual General Meeting
05/04/2004	Research Update
05/04/2004	New York visit by ReGen Chairman
19/03/2004	Notice of AGM
19/03/2004	Research Update
17/03/2004	Colostrinin (1) (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer’s disease
17/03/2004	Colostrinin™ Clinical Study is published in Journal of Alzheimer's Disease
13/02/2004	Notification of Change in Interests of Directors
12/02/2004	ReGen Therapeutics Plc Placing raises £500,000
12/02/2004	Preliminary results to 31 December 2003
26/01/2004	Disclosure of Notifiable Interest - Disposal of Shares

If you are unable to view the PDF documents you may need to download the free Adobe Reader